Full Length Research Paper
References
Abarikwu SO (2014). Kolaviron a natural flavonoid from the seeds of Garcinia kola reduces LPS-induced inflammation in macrophages by combined inhibition of IL-6 secretion, and inflammatory transcription factors, ERK1/2, NF-KB, p38, Akt,p-cJUN and JNK. Biophys. Acta 1840:2373-2381. |
|
Adegbehingbe OO, Adesanya SA, Idowu TO, Okimi OC, Oyelami OA, Iwalewa EO (2008). Clinical effects of Garcinia kola in knee osteoarthritis. J. Orthopaed. Surg. Res. 3(1):34. |
|
Akaike H (1974). A New Look at the Statistical Model Identification. IEEE Trans. Autom. Control 19(6):716-723. |
|
Anighoro A, Bajorath J, Rastelli G (2014). Polypharmacology: Challenges and opportunities in drug discovery. J. Med. Chem. 57:7874-7887. |
|
Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas, PR, Betz JM, Sempos CT, Picciano MF (2011). Dietary supplement use in the United States, 2003–2006. J. Nutr. 141(2):261-266. |
|
Bernal J, Mendiola JA, Ibá-ez E, Cifuentes A (2011). Advanced analysis of nutraceuticals. J. Pharm. Biomed. Anal. 55(4):758-774. |
|
Block G, Cox C, Madans J, Schreiber GB, Licitra L, Melia N (1988). Vitamin supplement use, by demographic characteristics. Am. J. Epidemiol. 127(2):297-309. |
|
Derbre S, Morel S, Richomme P, Toure AK (2014). Anti-glycation agent comprising a Garcinia kola extract or fraction. United States Patent Application Publication, US 9107849, 1–9. |
|
Farombi EO (2000). Mechanisms for the hepatoprotective action of kolaviron: studies on hepatic enzymes, microsomal lipids and lipid peroxidation in carbontetrachloride-treated rats. Pharmacol. Res. 42(1):75-80. |
|
Farombi EO (2003). African indigenous plants with chemotherapeutic potentials and biotechnological approach to the production of bioactive prophylactic agents. Afr. J. Biotechnol. 2(12):662-671. |
|
Farombi EO, Adedara IA, Ajayi BO, Ayepola OR, Egbeme EE (2013a). Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats. Basic Clin. Pharmacol. Toxicol. 113(1):49-55. |
|
Farombi EO, Adedara IA, Oyenihi AB, Ekakitie E, Kehinde S (2013b). Hepatic, testicular and spermatozoa antioxidant status in rats chronically treated with Garcinia kola seed. J. Ethnopharmacol. 146(2):536-542. |
|
Farombi EO, Adepoju BF, Ola-Davies OE, Emerole GO (2005). Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural bioflavonoid of Garcinia kola seeds. Eur. J. Cancer Prev. 14(3):207-214. |
|
Farombi EO, Akanni OO, Emerole GO (2002). Antioxidant and Scavenging Activities of Flavonoid Extract (Kolaviron) of Garcinia kola Seeds. Pharm. Biol. 40(2):107-116. |
|
Farombi EO, Hansen M, Ravn-Haren G, Moller P, Dragsted LO (2004a). Commonly consumed and naturally occuring dietary substances affect biomarkers of oxidative stress and DNA damage in healthy rats. Food Chem. Toxicol. 42(8):1315-1322. |
|
Farombi EO, Moller P, Dragsted LO (2004b). Ex-vivo and in vitro protective effects of kolaviron against oxygen-derived radical-induced DNA damage and oxidative stress in human lymphocytes and rat liver cells. Cell Biol. Toxicol. 20(2):71-82. |
|
Farombi EO, Shrotriya S, Surh YJ (2009). Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1. Life Sci. 84(5-6):149-155. |
|
Feuereisen MM, Barraza MG, Zimmermann BF, Schieber A, Schulze-Kaysers N (2017). Pressurized liquid extraction of anthocyanins and biflavonoids from Schinus terebinthifolius Raddi: A multivariate optimization. Food Chem. 214:564-571. |
|
Idowu SO (2014). Computational antioxidant capacity simulation (CAOCS): A novel framework of antioxidant capacity profiling. Chem. Prod. Proc. Model. 9(1):25-43. |
|
Idowu SO, Adeyemo MA, Itiola AJ (2009). Computational models for the determination of antioxidant capacity and phenolics in dietary supplements using real-time proton transfer kinetics data. Chem. Prod. Proc. Model. 4(1):41. |
|
Irvine FR (1961). Woody plants of Ghana. Oxford University Press, Oxford. |
|
Iwu MM (1985). Antihepatoxic constituents of Garcinia kola seeds. Experientia 41(5):699-700. |
|
Iwu MM, Igboko AA, Onwuchekwa UA Okunji CO (1987). Evaluation of the antihepatotoxic activity of the biflavonoids of Garcinia kola seed. J. Ethnopharmacol. 21:127-138. |
|
Konziase B (2015). Protective activity of biflavanones from Garcinia kola against Plasmodium infection. J. Ethnopharmacol. 172:214-218. |
|
Koo SY, Cha KH, Song DG, Chung D, Pan CH (2012). Optimization of pressurized liquid extraction of zeaxanthin from Chlorella ellipsoidea. J. Appl. Phycol. 24(4):725-730. |
|
Koplan JP, Annest JL, Layde PM, Rubin GL (1986). Nutrient intake and supplementation in the United States (NHANES II). Am. J. Public Health 76(3):287-289. |
|
Mister S (2012). Introduction. In. A. Dickinson (Ed.), The benefits of nutritional supplements (4th ed.). Washington D.C.: Council for Responsible Nutrition. |
|
Nwaneri-Chidozie VO, Anyanwu KC, Adaramoye OA Emerole GO. (2014). Cardioprotective effect of kolaviron (Garcinia kola seed extract) in cholesterol-fed rats. Int. J. Pharm. Sci. Res. 5(3):96-99. |
|
Nworu CS, Akah PA, Esimone CO, Okoli CO, Okoye FBC (2008). Immunomodulatory activities of kolaviron, a mixture of three related biflavonoids of Garcinia kola Heckel. Immunopharmacol. Immunotoxicol. 30(2):317-332. |
|
Okunji C, Komarnytsky S, Fear G, Poulev A, Ribnicky DM, Awachie PI, Ito Y, Raskin I (2007). Preparative isolation and identification of tyrosinase inhibitors from the seeds of Garcinia kola by high-speed counter-current chromatography. J. Chromatogr. A 1151(1-2):45-50. |
|
Olaleye SB, Farombi EO, Owoeye BV, Onasanwo SA, Elegbe RA (2000). Analgesic and anti-inflammatory effects of kolaviron (a Garcinia kola seed extract). Afr. J. Biomed. Res. 3:171-174. |
|
Onasanwo SA, Velagapudi R Ol-Bakoush A, Olajide OA (2016). Inhibition of neruoinflammation in BV2 microglia by the biflavonoid kolaviron is dependent on the Nrf2/ARE antioxidant protoective mechanism. Mol. Cell. Biochem. 414(1):23-36. |
|
Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF (2004). Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am. J. Epidemiol. 160(4):339-349. |
|
Sewani-Rusike CR, Ralebona N, Nkeh-Chungag BN (2016). Dose-and time-dependent effects of Garcinia kola seed extract on sexual behaviour and reproductive parameters in male Wistar rats. Andrologia 48(3):300-307. |
|
Simon Z, Peragovics A, Vigh-Smeller M, Csukly G, Tombor L, Yang Z, Zahoranszky-Kohalmi G, Vegner L, Jelinek B, Hari P, Hetenyi C, Bitter I, Czobor P, Malnasi-Csizmadia A (2012). Drug effect prediction by polypharmacology-based interaction profiling. J. Chem. Inf. Model. 52(1):134-145. |
|
Trans-Atlantic Business Dialogue (TABD) Dietary Supplement Expert Group (2002). Good Manufacturing Practices (GMP's) for Dietary Supplements, 1–8. Retrieved from View , Accessed on 18 March, 2017. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0